Compare OGC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGC | LNTH |
|---|---|---|
| Founded | 1990 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.5B |
| IPO Year | 2010 | 2014 |
| Metric | OGC | LNTH |
|---|---|---|
| Price | $25.65 | $100.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $106.99 |
| AVG Volume (30 Days) | 371.6K | ★ 965.0K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.91 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $41.93 | N/A |
| Revenue Next Year | $0.30 | $12.19 |
| P/E Ratio | ★ N/A | $34.35 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $21.90 | $50.16 |
| 52 Week High | $31.90 | $111.86 |
| Indicator | OGC | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 36.42 | 46.56 |
| Support Level | $21.90 | $99.77 |
| Resistance Level | $25.18 | $100.40 |
| Average True Range (ATR) | 0.92 | 0.35 |
| MACD | -0.16 | 0.03 |
| Stochastic Oscillator | 16.12 | 34.21 |
OceanaGold Corp is a growing intermediate gold and copper producer committed to safely and responsibly maximizing the generation of Free Cash Flow from its operations and delivering robust returns for its shareholders. It has a portfolio of four operating mines: the Haile Gold Mine in the United States of America; the Didipio Mine in the Philippines; and the Macraes and Waihi operations in New Zealand. The company generates key revenue from Haile mines.
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.